CCaaS Sr Engineer (Technology)
DaVita Kidney Care
Summary
The Senior CCaaS Engineer is responsible for architecting, optimizing, and supporting the cloud-based communication ecosystem, serving as a primary subject matter expert for NICE CXone.
Job description
Rather than simply establishing systems from scratch, this role dives deep into complex, existing architectures to enhance system performance, drive seamless integrations across enterprise platforms, and spearhead the adoption of next-generation AI and voice technologies.
The ideal candidate will thrive in a dynamic technical environment, provide high-level mentorship to engineering teams, and confidently lead root-cause resolution for major events across our diverse contact center landscape.
Requirements
- Deep expertise in complex communication architectures
- Subject matter expert for NICE CXone
- Ability to provide high-level mentorship to engineering teams
- Capable of leading root-cause resolution for major technical events
- Experience in contact center environment
Benefits
- 401(k) Matching
- Healthcare Coverage
Company overview
DaVita Kidney Care is a leading American healthcare provider specializing in kidney dialysis services, operating as one of the largest dialysis companies in the United States. Founded in 1992 and headquartered in Denver, Colorado, DaVita operates a vast network of 2,675 outpatient dialysis centers across the United States, serving approximately 200,800 patients, with an additional 367 centers in 11 other countries serving 49,400 patients. The company primarily treats end-stage renal disease (ESRD), providing life-sustaining dialysis treatments that patients typically require three times per week. DaVita holds approximately 37% market share in the U.S. dialysis market and is publicly traded on the New York Stock Exchange under the ticker DVA. The company's name, derived from the Italian phrase "Dare Vita" meaning "to give life," reflects its mission to provide essential kidney care services. With approximately 76,000 employees, DaVita has established itself as a Fortune 500 company and a significant player in the healthcare industry, with Berkshire Hathaway owning a 41.2% stake in the organization.